Allarity Therapeutics Inc (ALLR) FinancialsALLRAllarity Therapeutics Inc

Evaluating the bottom line, Allarity Therapeutics Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -21436.00%, while the net margin is -24620.00%. These profitability ratios, combined with a Return on Equity (ROE) of -157.09%, provide a clear picture of how effectively ALLR converts its operational activities into shareholder value.

In the context of the broader market, ALLR competes directly with industry leaders such as COSM and ABVC. With a market capitalization of $21.80M, it holds a significant position in the sector. When comparing efficiency, ALLR's gross margin of 100.00% stands against COSM's 6.12% and ABVC's N/A. Such benchmarking helps identify whether Allarity Therapeutics Inc is trading at a premium or discount relative to its financial performance.

The company reported a revenue of $0.32 million for FY 2025, with a net loss of $11.2 million, indicating ongoing financial struggles but some improvement in loss reduction.